Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer.
In the absence of curative therapies, treatment of metastatic castrate-resistant prostate cancer (mCRPC) using currently available drugs can be improved by integrating evolutionary principles that govern proliferation of resistant subpopulations into current treatment protocols. Here we develop what...
Shranjeno v:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Public Library of Science (PLoS)
2020-01-01
|
| Serija: | PLoS ONE |
| Online dostop: | https://doi.org/10.1371/journal.pone.0243386 |
| Oznake: |
Brez oznak, prvi označite!
|